Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Inventory: 2020-2024

Historic Inventory for Biofrontera (BFRI) over the last 5 years, with Dec 2024 value amounting to $6.6 million.

  • Biofrontera's Inventory fell 33.67% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 33.67%. This contributed to the annual value of $6.6 million for FY2024, which is 39.07% down from last year.
  • Biofrontera's Inventory amounted to $6.6 million in FY2024, which was down 39.07% from $10.9 million recorded in FY2023.
  • Biofrontera's 5-year Inventory high stood at $10.9 million for FY2023, and its period low was $4.5 million during FY2021.
  • Its 3-year average for Inventory is $8.2 million, with a median of $7.2 million in 2022.
  • Its Inventory has fluctuated over the past 5 years, first surged by 60.79% in 2022, then plummeted by 39.07% in 2024.
  • Biofrontera's Inventory (Yearly) stood at $7.1 million in 2020, then crashed by 37.13% to $4.5 million in 2021, then surged by 60.79% to $7.2 million in 2022, then soared by 52.18% to $10.9 million in 2023, then slumped by 39.07% to $6.6 million in 2024.